← Open Payments lookup

EMMANUEL GBALA: Open Payments

NPI 1245862648 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$640 in 27 payments from 8 companies in 2025. Trend: 2023 $278 · 2024 $692 · 2025 $640

Food & beverage: $640
CompanyPaymentsAmount
ABBVIE INC.15$314
Teva Pharmaceuticals USA, Inc.2$128
Vanda Pharmaceuticals Inc.3$56
Alkermes, Inc.2$45
Tris Pharma Inc2$44
Lundbeck LLC1$26
Otsuka America Pharmaceutical, Inc.1$17
TMS NeuroHealth Centers Inc.1$11

Products named: VRAYLAR, UZEDY, FANAPT, ARISTADA, Dyanavel XR, REXULTI, TMS NeuroHealth Centers Inc..

Industry payments across MD — which companies pay providers there.